| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403063 Applying polyurea; curing |
| 06/11/2002 | US6403057 Microcapsules, method of making and their use |
| 06/11/2002 | US6402037 Two-photon upconverting dyes and applications |
| 06/11/2002 | CA2323849C Orally administrable solid ribavirin dosage forms and process for making them |
| 06/11/2002 | CA2262692C Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 06/11/2002 | CA2240777C Triazole derivatives useful in therapy |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/11/2002 | CA2239170C Improved perfluorocarbons for biological gas exchange and method |
| 06/11/2002 | CA2232267C Novel imidazole lipoxygenase inhibitors |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | CA2169839C Antipsychotic method |
| 06/11/2002 | CA2169838C Antipsychotic method |
| 06/11/2002 | CA2159596C Method of producing liposomes |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2112084C Antidepressant and antiparkinsonian compounds |
| 06/11/2002 | CA2103666C Products containing verapamil and trandolapril |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2074050C Diclofenac sodium plaster |
| 06/11/2002 | CA2057441C Synthetic conversion of bryostatin 2 into bryostatin 1 |
| 06/11/2002 | CA2048638C Fibroblast growth factor (fgf)-based stabilized compositions and the use thereof |
| 06/11/2002 | CA2031756C Isatine derivatives, their preparation and use |
| 06/07/2002 | CA2360127A1 Method for treating chronic obstructive pulmonary disease |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044420A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044403A2 Markers for testing analogs of vitamin d and therapeutical uses |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002044371A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044334A2 Recombinant rsv virus expression systems and vaccines |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044218A1 Compound of hydroxamic acid derivative and hyaluronic acid |
| 06/06/2002 | WO2002044194A1 L-nucleic acid derivatives and processes for the synthesis thereof |
| 06/06/2002 | WO2002044187A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | WO2002044184A2 Dna methyl transferase inhibitors |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists |
| 06/06/2002 | WO2002044180A1 Lactam compounds and medicinal use thereof |
| 06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 06/06/2002 | WO2002044175A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 06/06/2002 | WO2002044172A1 Morpholine derivatives as antagonists of orexin receptors |
| 06/06/2002 | WO2002044171A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 06/06/2002 | WO2002044170A2 Benzothiophene derivative compounds, process of preparation and use thereof |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044167A1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044164A1 0ovel farnesyl protein transferase inhibitors |
| 06/06/2002 | WO2002044162A1 Chromatographic separation method of paclitaxel and cephalomannin |
| 06/06/2002 | WO2002044161A2 A process for the preparation of taxan derivatives |
| 06/06/2002 | WO2002044160A1 Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis |
| 06/06/2002 | WO2002044159A2 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/06/2002 | WO2002044158A1 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044152A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 06/06/2002 | WO2002044151A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers |
| 06/06/2002 | WO2002044149A1 Indole and dihydroindole derivatives |
| 06/06/2002 | WO2002044147A1 Process for preparing distamycin derivatives |
| 06/06/2002 | WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors |
| 06/06/2002 | WO2002044142A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002044137A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 06/06/2002 | WO2002044133A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | WO2002044131A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044130A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044129A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044126A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | WO2002043807A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
| 06/06/2002 | WO2002043806A2 In vivo delivery methods and compositions |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043772A2 Water-soluble polymer conjugates of triazine derivatives |
| 06/06/2002 | WO2002043771A2 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | WO2002043769A2 Neutral and anionic colloidal particles for gene delivery |
| 06/06/2002 | WO2002043768A1 Molecular inclusion compounds consisting of biocatalytically obtained, linear, water-insoluble polysaccharides and of fatty acids or their derivatives |
| 06/06/2002 | WO2002043765A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 06/06/2002 | WO2002043764A1 Behavior chemotherapy |
| 06/06/2002 | WO2002043763A2 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043761A1 Antiobestic agents and health foods |
| 06/06/2002 | WO2002043760A1 Saccharometabolism activators |
| 06/06/2002 | WO2002043744A1 Excretion accelerator for accumulative chlorine compound |
| 06/06/2002 | WO2002043743A1 Light stabilized antimicrobial materials |
| 06/06/2002 | WO2002043742A1 Cyclodextrins and reversal of atherosclerosis |
| 06/06/2002 | WO2002043741A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | WO2002043740A1 Method for producing an immunotropic antiviral preparation |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | WO2002043738A2 Use of bisphosphonates for pain treatment |
| 06/06/2002 | WO2002043737A1 Treatment of chronic fatigue syndrome and fibromyalgia syndrome |
| 06/06/2002 | WO2002043736A1 Beautifying foods and drinks and peroral beautifying preparations |
| 06/06/2002 | WO2002043735A1 Inhibitors of thrombin induced platelet aggregation |
| 06/06/2002 | WO2002043734A1 Novel compounds |